BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35492241)

  • 21. Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions.
    Gupta D; Patterson AM; Osborne-Lawrence S; Bookout AL; Varshney S; Shankar K; Singh O; Metzger NP; Richard CP; Wyler SC; Elmquist JK; Zigman JM
    Mol Metab; 2021 Nov; 53():101258. PubMed ID: 34023483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ups and downs of growth hormone secretagogue receptor signaling.
    Cornejo MP; Mustafá ER; Cassano D; Banères JL; Raingo J; Perello M
    FEBS J; 2021 Dec; 288(24):7213-7229. PubMed ID: 33460513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ghrelin mediates exercise endurance and the feeding response post-exercise.
    Mani BK; Castorena CM; Osborne-Lawrence S; Vijayaraghavan P; Metzger NP; Elmquist JK; Zigman JM
    Mol Metab; 2018 Mar; 9():114-130. PubMed ID: 29396372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline.
    Tian J; Guo L; Wang T; Jia K; Swerdlow RH; Zigman JM; Du H
    JCI Insight; 2023 May; 8(10):. PubMed ID: 37212281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and characterization of a triazole-based growth hormone secretagogue receptor modulator inhibiting the glucoregulatory and feeding actions of ghrelin.
    Péraldi-Roux S; Bayle M; M'Kadmi C; Damian M; Vaillé J; Fernandez G; Cornejo MP; Marie J; Banères JL; Ben Haj Salah K; Fehrentz JA; Cantel S; Perello M; Denoyelle S; Oiry C; Neasta J
    Biochem Pharmacol; 2022 Aug; 202():115114. PubMed ID: 35659880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Coexpression of the Ghrelin and LEAP2 Receptor GHSR With Pancreatic Polypeptide in Mouse and Human Islets.
    Gupta D; Dowsett GKC; Mani BK; Shankar K; Osborne-Lawrence S; Metzger NP; Lam BYH; Yeo GSH; Zigman JM
    Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34289060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling.
    Mustafá ER; Cordisco González S; Damian M; Cantel S; Denoyelle S; Wagner R; Schiöth HB; Fehrentz JA; Banères JL; Perelló M; Raingo J
    Front Pharmacol; 2021; 12():712437. PubMed ID: 34447311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone secretagogue receptor in dopamine neurons controls appetitive and consummatory behaviors towards high-fat diet in ad-libitum fed mice.
    Cornejo MP; Barrile F; Cassano D; Aguggia JP; García Romero G; Reynaldo M; Andreoli MF; De Francesco PN; Perello M
    Psychoneuroendocrinology; 2020 Sep; 119():104718. PubMed ID: 32535402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying the binding mechanism of LEAP2 to receptor GHSR1a.
    Wang JH; Li HZ; Shao XX; Nie WH; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2019 Apr; 286(7):1332-1345. PubMed ID: 30666806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic insights from a GHSR-A203E mutant mouse model.
    Torz LJ; Osborne-Lawrence S; Rodriguez J; He Z; Cornejo MP; Mustafá ER; Jin C; Petersen N; Hedegaard MA; Nybo M; Damonte VM; Metzger NP; Mani BK; Williams KW; Raingo J; Perello M; Holst B; Zigman JM
    Mol Metab; 2020 Sep; 39():101004. PubMed ID: 32339772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of ghrelin and LEAP2 in patients with type 2 diabetes mellitus: correlation with circulating glucose and lipids.
    Li J; Huang P; Xiong J; Liang X; Li M; Ke H; Chen C; Han Y; Huang Y; Zhou Y; Luo Z; Feng D; Chen C
    Endocr Connect; 2022 May; 11(5):. PubMed ID: 35521798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Fat Diet Induces Resistance to Ghrelin and LEAP2 Peptide Analogs in Mice.
    Holá L; Tureckiuová T; Kuneš J; Železná B; Maletínská L
    Physiol Res; 2023 Nov; 72(5):607-619. PubMed ID: 38015760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward a consensus nomenclature for ghrelin, its non-acylated form, liver expressed antimicrobial peptide 2 and growth hormone secretagogue receptor.
    Perelló M; Dickson SL; Zigman JM; Leggio L;
    J Neuroendocrinol; 2023 Jan; 35(1):e13224. PubMed ID: 36580314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE INTRIGUING LIGAND-DEPENDENT AND LIGAND-INDEPENDENT ACTIONS OF THE GROWTH HORMONE SECRETAGOGUE RECEPTOR ON REWARD-RELATED BEHAVIORS.
    Cornejo MP; Mustafá ER; Barrile F; Cassano D; De Francesco PN; Raingo J; Perello M
    Neurosci Biobehav Rev; 2021 Jan; 120():401-416. PubMed ID: 33157147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rats with a truncated ghrelin receptor (GHSR) do not respond to ghrelin, and show reduced intake of palatable, high-calorie food.
    MacKay H; Charbonneau VR; St-Onge V; Murray E; Watts A; Wellman MK; Abizaid A
    Physiol Behav; 2016 Sep; 163():88-96. PubMed ID: 27129673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis.
    Francisco V; Tovar S; Conde J; Pino J; Mera A; Lago F; González-Gay MA; Dieguez C; Gualillo O
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32268520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of peripheral ghrelin signaling via the vagus nerve in ghrelin receptor-restored GHSR-null mice.
    Okada T; Waise TMZ; Toshinai K; Mita Y; Sakoda H; Nakazato M
    Neurosci Lett; 2018 Aug; 681():50-55. PubMed ID: 29802915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor.
    Sun Y; Wang P; Zheng H; Smith RG
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4679-84. PubMed ID: 15070777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 Fragment.
    Hagemann CA; Zhang C; Hansen HH; Jorsal T; Rigbolt KTG; Madsen MR; Bergmann NC; Heimbürger SMN; Falkenhahn M; Theis S; Breitschopf K; Holm S; Hedegaard MA; Christensen MB; Vilsbøll T; Holst B; Vrang N; Jelsing J; Knop FK
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e966-e981. PubMed ID: 33135737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes".
    Gupta D; Ogden SB; Shankar K; Varshney S; Zigman JM
    Mol Metab; 2021 Apr; 46():101128. PubMed ID: 33246141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.